PATENT CLAIM ANALYSIS

Application Number: 15884745
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-08
Patent Classification: ["424", "469000"]

Abstract:
This invention relates to abuse-deterrent pharmaceutical compositions and dosage forms and manufacturing processes thereof, the compositions comprising an agonist and antagonist that are difficult to separate visually, physically, or chemically. The compositions comprise a tacky amorphous polymer and a crystalline polymer curing agent for the amorphous polymer such that the agonist is releasable and the antagonist is non-releasable unless the dosage forms are tampered with. The non-extractable dosage forms reduce the potential for prescription drug abuse.

Claim (Index 36):
The non-extractable oral solid dosage form of  claim 1 , wherein the amount of the tacky amorphous polymer in each of the first particle and the second particle is from about 10% to about 75% w/w.

Metadata:
- Claim Count in Document: 73.0
- Percentile: 86.0
- Lexical Diversity: 1.60784
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13718879', '13544333', '12909614', '10689866', '10700861']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7544966163450633
- 35 USC 102 Novelty (BERT): 0.5226021346892847
- Combined Prediction Score: 0.7313071681794855
- Mean Citation Score: 308.175238
- Max Citation Score: 311.86154
- Similarity Product: 186.0903500723016

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test